Association of rare protein-truncating DNA variants in APOB or PCSK9 with low-density lipoprotein cholesterol level and risk of coronary heart disease

JS Dron, AP Patel, Y Zhang, SJ Jurgens… - JAMA …, 2023 - jamanetwork.com
Importance Protein-truncating variants (PTVs) in apolipoprotein B (APOB) and proprotein
convertase subtilisin/kexin type 9 (PCSK9) are associated with significantly lower low …

PharmGWAS: a GWAS-based knowledgebase for drug repurposing

H Kang, S Pan, S Lin, YY Wang, N Yuan… - Nucleic Acids …, 2024 - academic.oup.com
Leveraging genetics insights to promote drug repurposing has become a promising and
active strategy in pharmacology. Indeed, among the 50 drugs approved by FDA in 2021, two …

Adjusting for common variant polygenic scores improves yield in rare variant association analyses

SJ Jurgens, JP Pirruccello, SH Choi, VN Morrill… - Nature Genetics, 2023 - nature.com
With the emergence of large-scale sequencing data, methods for improving power in rare
variant association tests are needed. Here we show that adjusting for common variant …

[HTML][HTML] Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data

J Lanillos, M Carcajona, P Maietta, S Alvarez… - npj Genomic …, 2022 - nature.com
Exome sequencing is utilized in routine clinical genetic diagnosis. The technical robustness
of repurposing large-scale next-generation sequencing data for pharmacogenetics has …

[PDF][PDF] An RNA-informed dosage sensitivity map reflects the intrinsic functional nature of genes

D Dong, H Shen, Z Wang, J Liu, Z Li, X Li - The American Journal of …, 2023 - cell.com
Understanding dosage sensitivity or why Mendelian diseases have dominant vs. recessive
modes of inheritance is crucial for uncovering the etiology of human disease. Previous …

Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank

B Li, K Sangkuhl, R Whaley, M Woon, K Keat… - The American Journal of …, 2023 - cell.com
Pharmacogenomics (PGx) is an integral part of precision medicine and contributes to the
maximization of drug efficacy and reduction of adverse drug event risk. Accurate information …

RNA interference in the era of nucleic acid therapeutics

V Jadhav, A Vaishnaw, K Fitzgerald, MA Maier - Nature Biotechnology, 2024 - nature.com
Two decades of research on RNA interference (RNAi) have transformed a breakthrough
discovery in biology into a robust platform for a new class of medicines that modulate mRNA …

[PDF][PDF] CNest: A novel copy number association discovery method uncovers 862 new associations from 200,629 whole-exome sequence datasets in the UK Biobank

T Fitzgerald, E Birney - Cell Genomics, 2022 - cell.com
Copy number variation (CNV) is known to influence human traits, having a rich history of
research into common and rare genetic disease, and although CNV is accepted as an …

[HTML][HTML] Human exome sequencing and prospects for predictive medicine: analysis of international data and own experience

OS Glotov, AN Chernov, AS Glotov - Journal of Personalized Medicine, 2023 - mdpi.com
Today, whole-exome sequencing (WES) is used to conduct the massive screening of
structural and regulatory genes in order to identify the allele frequencies of disease …

[PDF][PDF] Systematic elucidation of genetic mechanisms underlying cholesterol uptake

MC Hamilton, JD Fife, E Akinci, T Yu, B Khowpinitchai… - Cell Genomics, 2023 - cell.com
Genetic variation contributes greatly to LDL cholesterol (LDL-C) levels and coronary artery
disease risk. By combining analysis of rare coding variants from the UK Biobank and …